- Part 1 Principles of international endocrine practice
- Part 2 Pituitary and hypothalamic diseases
- Part 3 The thyroid
- Part 4 Parathyroid, calcium, and bone metabolism
- Part 5 The adrenal gland and endocrine hypertension
- Part 6 Neuroendocrine tumours and genetic disorders
- Part 7 Growth and development during childhood
- Part 8 Female endocrinology and pregnancy
- Part 9 Male hypogonadism and infertility
- Part 10 Endocrinology of ageing and systemic disease
- Part 11 Endocrinology of cancer
- Part 12 Obesity, lipids, and metabolic disorders
- Part 13 Diabetes mellitus
- 13.1 Classification and diagnosis of diabetes mellitus
- 13.2 Aetiology and pathogenesis of type 1 diabetes mellitus
- 13.3 Aetiology and pathogenesis of type 2 diabetes mellitus
- 13.4 Management of diabetes mellitus
- 13.4.1 Clinical features, lifestyle management, and glycaemic targets in type 2 diabetes mellitus
- 13.4.2 Pharmacological therapy of hyperglycaemia in type 2 diabetes mellitus
- 13.4.3 Diabetes in diverse ethnic groups
- 13.4.4 Structured education for people with type 2 diabetes mellitus
- 13.4.5 Metabolic surgery in the treatment of type 2 diabetes mellitus
- 13.4.6 Management of type 1 diabetes mellitus
- 13.4.7 Type 1 and type 2 diabetes mellitus in children
- 13.4.8 Hypoglycaemia in the treatment of diabetes mellitus
- 13.4.9 Non-biological technologies in glucose sensing
- 13.4.9.1 Glucose monitoring
- 13.4.9.2 Closing the loop
- 13.4.10 Management of diabetes mellitus in special situations
- 13.5 Microvascular complications
- 13.6 Macrovascular diseases and diabetes mellitus
- 13.7 The diabetic foot
- 13.8 Mental health and diabetes mellitus
- 13.9 Organization of diabetes care
- 13.10 Transplantation in Diabetes
- 13.11 Gene therapy in diabetes mellitus
Non-biological technologies in glucose sensing
Blood glucose concentrations are measured in diabetes to detect hyper- and hypo-glycaemia. Health care professionals need this information to diagnose diabetes, or states of impaired glucose tolerance, to adjust therapy and correct hyper- and hypo-glycaemia in established diabetes, to interpret signs and symptoms in patients (e.g. is confusion due to hypoglycaemia or another cause?), and to assess the risk of tissue complications developing in the future (the severity and duration of hyperglycaemia is clearly related to microvascular disease). The patient with diabetes measures blood glucose concentrations to take corrective action with food and insulin, to maintain good control, to check the safety of everyday activities (e.g. not driving when hypoglycaemic), to assess the impact of events and lifestyle and on control (exercise, diet, illness, psychological stress), and to ensure a good quality of life and the ‘peace of mind’ that knowledge of the blood glucose concentration gives.
Glucose monitoring has traditionally been performed by intermittent sampling of blood glucose concentrations, either in hospital or by the patient testing their own blood glucose concentrations at home using finger-prick capillary blood samples applied to reagent strips and inserted into portable glucose meters – self-monitoring of blood glucose (SMBG). In addition, in the last decade or so, continuous glucose monitoring (CGM) has entered clinical practice as a supplement to SMBG, albeit with limited uptake at present. CGM is based on the implantation of needle-type glucose sensors, or microdialysis probes, into the subcutaneous tissue for measurement of interstitial glucose concentrations.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Part 1 Principles of international endocrine practice
- Part 2 Pituitary and hypothalamic diseases
- Part 3 The thyroid
- Part 4 Parathyroid, calcium, and bone metabolism
- Part 5 The adrenal gland and endocrine hypertension
- Part 6 Neuroendocrine tumours and genetic disorders
- Part 7 Growth and development during childhood
- Part 8 Female endocrinology and pregnancy
- Part 9 Male hypogonadism and infertility
- Part 10 Endocrinology of ageing and systemic disease
- Part 11 Endocrinology of cancer
- Part 12 Obesity, lipids, and metabolic disorders
- Part 13 Diabetes mellitus
- 13.1 Classification and diagnosis of diabetes mellitus
- 13.2 Aetiology and pathogenesis of type 1 diabetes mellitus
- 13.3 Aetiology and pathogenesis of type 2 diabetes mellitus
- 13.4 Management of diabetes mellitus
- 13.4.1 Clinical features, lifestyle management, and glycaemic targets in type 2 diabetes mellitus
- 13.4.2 Pharmacological therapy of hyperglycaemia in type 2 diabetes mellitus
- 13.4.3 Diabetes in diverse ethnic groups
- 13.4.4 Structured education for people with type 2 diabetes mellitus
- 13.4.5 Metabolic surgery in the treatment of type 2 diabetes mellitus
- 13.4.6 Management of type 1 diabetes mellitus
- 13.4.7 Type 1 and type 2 diabetes mellitus in children
- 13.4.8 Hypoglycaemia in the treatment of diabetes mellitus
- 13.4.9 Non-biological technologies in glucose sensing
- 13.4.9.1 Glucose monitoring
- 13.4.9.2 Closing the loop
- 13.4.10 Management of diabetes mellitus in special situations
- 13.5 Microvascular complications
- 13.6 Macrovascular diseases and diabetes mellitus
- 13.7 The diabetic foot
- 13.8 Mental health and diabetes mellitus
- 13.9 Organization of diabetes care
- 13.10 Transplantation in Diabetes
- 13.11 Gene therapy in diabetes mellitus